Genadyne Agrees to Distribution Pact With InfuSystem for Negative Pressure Wound Therapy Systems

InfuSystem Holdings Inc. has cut a national distribution deal with Genadyne Biotechnologies Inc. for its negative pressure wound therapy (NPWT) systems and supplies.

Under the agreement’s terms, InfuSystem will offer Genadyne’s complete line of wound care products, including its most advanced XLR8 Plus NPWT Pump, which delivers advanced variable pressure capabilities with a gradual wave, in conjunction with Genadyne’s proprietary XLR8 Dressing Kit with Silver, an antimicrobial contact layer to protect the wound.
 
“We are pleased to partner with Genadyne in providing our customers with access to their advanced negative pressure wound therapy systems and supplies,” InfuSystem CEO Richard DiIorio said. “These products are manufactured in the U.S. This agreement represents a second NPWT device offering that will help to mitigate supply chain issues and provide our customers with multiple options. Our goal through our SI Wound Care partnership is to provide our patients and partners with a seamless offering of wound care products to promote healing, improve patient outcomes, and lower the cost of care. We look forward to a long and mutually beneficial relationship.”
 
Genadyne is focused on creating products for advanced wound healing—medical devices and products that help provide better care outcomes, speed patients’ healing time, and ultimately improve quality of life. Genadyne specializes in NPWT systems and advanced wound dressings that decrease the risk of pressure ulcer development. Headquartered in New York City, Genadyne sells its wound care products worldwide in more than 55 countries. All Genadyne products are manufactured and assembled in multiple manufacturing plants in the United States.
 
InfuSystem Holdings Inc. is a national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services (ITS), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy, and Lymphedema businesses. The second platform, Durable Medical Equipment Services (DME Services), supports the ITS platform and leverages service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Mich., the company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.